HALO sensor study for adults with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new sensor that may replace or improve current glucose monitors. You will still use your insulin pump, and the sensor measures glucose through a small implant under the skin. The study includes some planned challenges to see how the sensor responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have type 1 diabetes for at least 12 months
- You use an insulin pump (CSII) for your diabetes care
- You are willing to have frequent blood draws and take part in deliberate glucose, insulin, ketone, and lactate challenges
- You are willing to charge the sensor every day and avoid placing your usual CGM or insulin pump within 5 cm of the implant site
- You do not have certain health conditions or take certain medications that could make the challenges unsafe
- You do not have active implanted devices or certain blood disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the ROME GS System, a glucose monitoring device that measures blood sugar levels. The system includes a sensor placed under the skin and a transmitter worn on the body. If you have diabetes and want to help evaluate a new way to track your blood sugar, this trial may be for you.
This study tests a new glucose sensor placed inside a blood vessel to see how well it measures blood sugar. If you have diabetes and use intensive insulin therapy, this could be a way to help improve monitoring.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This study tests a new continuous glucose monitor (CGM) that checks your sugar levels day and night without frequent finger pricks. It may help you manage your diabetes better by showing glucose trends and alerts.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study is testing a new wearable sensor that tracks both glucose (sugar) and ketone levels continuously. It might help people with type 1 diabetes manage their condition better and avoid complications.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.